Division of Nuclear Medicine, Department of Radiology, State University of Campinas, Campinas, São Paulo, Brazil.
Urology. 2010 Aug;76(2):283-8. doi: 10.1016/j.urology.2009.12.032. Epub 2010 Mar 5.
To evaluate the utility of diuretic dynamic renal scintigraphy (DDRS) with technetium-99m-L,L-ethylenedicysteine ((99m)Tc-EC) in patients with indeterminate or possible false-positive results for urinary obstruction by technetium-99m diethylenetriamine penta-acetic acid ((99m)Tc-DTPA) DDRS.
A total of 92 patients (63 male; mean age, 16.6 +/- 21.25 years) were studied, with a total of 103 kidneys presenting indeterminate (20/103) or possible false-positive results for obstruction attributable to reduced renal function or severe kidney dilation (83/103) by (99m)Tc-DTPA DDRS (<60% of radiopharmaceutical excreted in 20 minutes-half-time clearance [T(1/2)] >15 minutes). Patients were reimaged after intravenous injection of (99m)Tc-EC, with dynamic images before and after furosemide administration using the same acquisition parameters applied in the previous (99m)Tc-DTPA study. Time interval between (99m)Tc-DTPA and (99m)Tc-EC renograms was 2-64 days. The percentage of excreted material 20 minutes after furosemide was calculated using both radiopharmaceuticals, and were statistically compared using the paired samples t test.
The excretion after furosemide injection was 25.3% +/- 18.2% for (99m)Tc-DTPA and 41.2% +/- 26.1% for (99m)Tc-EC, with a statistically significant difference between both radiopharmaceuticals (P <.0001). Using (99m)Tc-EC obstruction was excluded in 36 of 103 kidneys, which excreted >60%. A total of 10 of 83 kidneys (12.0%) with an obstructive pattern by (99m)Tc-DTPA study turned out to be indeterminate by (99m)Tc-EC DDRS. There was an agreement between (99m)Tc-EC and (99m)Tc-DTPA studies in 54 of 83 kidneys with obstructive (65.1%) and in 3 of 20 (15.0%) with indeterminate patterns.
(99m)Tc-EC was more effective than (99m)Tc-DTPA for excluding obstruction, presenting less false-positive and indeterminate results. (99m)Tc-EC can substitute (99m)Tc-DTPA to evaluate patients with urinary tract dilation.
评估使用放射性核素 99m-L,L-乙二胺二半胱氨酸(99mTc-EC)行利尿剂动态肾闪烁扫描(DDRS)对 99mTc-二乙三胺五乙酸(99mTc-DTPA)DDRS 诊断尿路梗阻呈不确定或可能假阳性结果的患者的应用价值。
共有 92 例患者(63 例男性;平均年龄 16.6±21.25 岁)参与研究,其中 103 个肾脏的 99mTc-DTPA DDRS 检查结果呈不确定(20/103)或可能假阳性(83/103),其原因是肾功能降低或严重肾扩张导致放射性药物排泄减少(20 分钟时放射性药物排泄半排期[T1/2]>15 分钟,<60%放射性药物排出)。患者在静脉注射 99mTc-EC 后再次进行扫描,使用与之前 99mTc-DTPA 研究相同的获取参数,在给予呋塞米前后进行动态图像采集。99mTc-DTPA 和 99mTc-EC 肾图之间的时间间隔为 2-64 天。使用两种放射性药物计算呋塞米后 20 分钟的排泄百分比,并使用配对样本 t 检验进行统计学比较。
呋塞米注射后,99mTc-DTPA 的排泄率为 25.3%±18.2%,99mTc-EC 的排泄率为 41.2%±26.1%,两种放射性药物之间存在统计学差异(P<.0001)。使用 99mTc-EC 后,103 个肾脏中有 36 个(36/103,34.9%)排泄>60%,可排除梗阻。83 个(83/103,80.6%)99mTc-DTPA 检查呈梗阻性模式的肾脏中,有 10 个(10/83,12.0%)用 99mTc-EC DDRS 检查结果为不确定。83 个(83/103,80.6%)梗阻性肾脏和 20 个(20/103,19.4%)不确定性肾脏中,99mTc-EC 与 99mTc-DTPA 检查结果一致的分别有 54 个(54/83,65.1%)和 3 个(3/20,15.0%)。
与 99mTc-DTPA 相比,99mTc-EC 对梗阻的排除效果更好,假阳性和不确定结果更少。99mTc-EC 可以替代 99mTc-DTPA 用于评估尿路扩张患者。